Atomoxetine Hydrochloride
Atomoxetine (brand name Strattera) is a norepinephrine reuptake inhibitor approved for the treatment of attention deficit hyperactivity disorder (ADHD).This compound is manufactured, marketed, and sold in the United States as the hydrochloride salt (atomoxetine HCl) under the brand name Strattera.
| Catalog Number | 10-101-111 |
| Alternative Name(s) | LY-135252, LY-139602, LY-139603, Tomoxetine Hydrochloride, (R)-(-)-N-Methyl-3-(o-tolyloxy)-3-phenylpropylamine · HCl, (R)-(-)-N-Methyl-γ-(2-methylphenoxy)-benzenepropanamine · HCl |
| Research Area | Attention deficit hyperactivity disorder (ADHD) |
| Molecular Formula | C17H21NO · HCl |
| CAS# | 82248-59-7 |
| Purity | >98% |
| Inchi | InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m1./s1 |
| Inchi Key | LUCXVPAZUDVVBT-UNTBIKODSA-N |
| SMILES | CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2.Cl |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/atomoxetine-hydrochloride-item-10-101-111-13.html |